Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells

Molecular Nutrition and Food Research

Volumn 55, Issue 5, 2011, Pages 733-748

  Yen, Jui Hung ^a   Weng, Ching Yi ^b   Li, Shiming ^c   Lo, Ya Hsuan ^b   Pan, Min Hsiung ^d   Fu, Shih Hang ^b   Ho, Chi Tang ^c   Wu, Ming Jiuan ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c RUTGERS UNIVERSITY   (United States)

^d NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

Author keywords

Acyl CoA:diacylglycerol acyltransferase 2; Atherogenesis; C Jun NH2 terminal kinase; CD36; Steroid response element binding protein 2

Indexed keywords

CD11B ANTIGEN; FLAVONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ITGAM PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR; NOBILETIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SCAVENGER RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL STRAIN HEPG2; CHEMISTRY; CITRUS FRUIT; CYTOLOGY; DRUG EFFECT; FOAM CELL; GENETICS; HUMAN; LIPID METABOLISM; MACROPHAGE; METABOLISM; MONOCYTE;

ANTIGENS, CD11B; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CITRUS; FLAVONES; FOAM CELLS; HEP G2 CELLS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; MACROPHAGES; MONOCYTES; NF-KAPPA B; PROTEIN KINASE C; RECEPTORS, LDL; RECEPTORS, SCAVENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1;

CITRUS;

EID: 79955636222     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000226     Document Type: Article

References (75)

1. Libby, P., Inflammation in atherosclerosis. Nature 2002, 420, 868-874.
2. Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P. et al., Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 1991, 88, 2039-2046.
3. Yamada, Y., Doi, T., Hamakubo, T., Kodama, T., Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system. Cell. Mol. Life Sci. 1998, 54, 628-640.
4. de Villiers, W. J., Smart, E. J., Macrophage scavenger receptors and foam cell formation. J. Leukoc. Biol. 1999, 66, 740-746.
5. Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P. et al., Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 2000, 105, 1049-1056.
6. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N. et al., A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997, 386, 292-296.
7. Babaev, V. R., Gleaves, L. A., Carter, K. J., Suzuki, H. et al., Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 2593-2599.
8. Sakaguchi, H., Takeya, M., Suzuki, H., Hakamata, H. et al., Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab. Invest. 1998, 78, 423-434.
9. Mehta, J. L., Sanada, N., Hu, C. P., Chen, J. et al., Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ. Res. 2007, 100, 1634-1642.
10. Hu, C., Chen, J., Dandapat, A., Fujita, Y. et al., LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J. Mol. Cell. Cardiol. 2008, 44, 76-83.
11. Brown, M. S., Goldstein, J. L., A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232, 34-47.
12. Scharnagl, H., Marz, W., New lipid-lowering agents acting on LDL receptors. Curr. Top. Med. Chem. 2005, 5, 233-242.
13. Kong, W., Wei, J., Abidi, P., Lin, M. et al., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004, 10, 1344-1351.
14. Phillips, N., Waters, D., Havel, R., Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993, 88, 2762-2770.
15. Benoist, F., Grand-Perret, T., ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools. Arterioscler. Thromb. Vasc. Biol. 1996, 16, 1229-1235.
16. Cases, S., Stone, S. J., Zhou, P., Yen, E. et al., Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 2001, 276, 38870-38876.
17. Tripoli, E., Guardia, M. L., Giammanco, S., Majo, D. D., Giammanco, M., Citrus flavonoids: molecular structure, biological activity and nutritional properties: a review. Food Chem. 2007, 104, 466-479.
18. Jeon, S. M., Park, Y. B., Choi, M. S., Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits. Clin. Nutr. 2004, 23, 1025-1034.
19. Kim, S. Y., Kim, H. J., Lee, M. K., Jeon, S. M. et al., Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet. J. Med. Food 2006, 9, 582-586.
20. Bok, S. H., Lee, S. H., Park, Y. B., Bae, K. H. et al., Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J. Nutr. 1999, 129, 1182-1185.
21. Kurowska, E. M., Manthey, J. A., Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. J. Agric. Food Chem. 2004, 52, 2879-2886.
22. Chiba, H., Uehara, M., Wu, J., Wang, X. et al., Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J. Nutr. 2003, 133, 1892-1897.
23. Jung, U. J., Kim, H. J., Lee, J. S., Lee, M. K. et al., Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin. Nutr. 2003, 22, 561-568.
24. Morin, B., Nichols, L. A., Zalasky, K. M., Davis, J. W. et al., The citrus flavonoids hesperetin and nobiletin differentially regulate low density lipoprotein receptor gene transcription in HepG2 liver cells. J. Nutr. 2008, 138, 1274-1281.
25. Kurowska, E., Manthey, J., Casaschi, A., Theriault, A., Modulation of hepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin. Lipids 2004, 39, 143-151.
26. Wilcox, L. J., Borradaile, N. M., de Dreu, L. E., Huff, M. W., Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP. J. Lipid Res. 2001, 42, 725-734.
27. Lee, C. H., Jeong, T. S., Choi, Y. K., Hyun, B. H. et al., Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem. Biophys. Res. Commun. 2001, 284, 681-688.
28. Whitman, S. C., Kurowska, E. M., Manthey, J. A., Daugherty, A., Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. Atherosclerosis 2005, 178, 25-32.
29. Eguchi, A., Murakami, A., Ohigashi, H., Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells. FEBS Lett. 2006, 580, 3321-3328.
30. Eguchi, A., Murakami, A., Li, S., Ho, C. T., Ohigashi, H., Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells. Biofactors 2007, 31, 107-116.
31. Lo, Y. H., Pan, M. H., Li, S., Yen, J. H. et al., Nobiletin metabolite, 3', 4'-dihydroxy-5, 6, 7, 8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells. Biochim. Biophys. Acta 2010, 1801, 114-126.
32. Li, S., Lo, C. Y., Ho, C. T., Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. J. Agric. Food Chem. 2006, 54, 4176-4185.
33. Li, S., Pan, M. H., Lai, C. S., Lo, C. Y. et al., Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines. Bioorg. Med. Chem. 2007, 15, 3381-3389.
34. Xiao, H., Yang, C. S., Li, S., Jin, H. et al., Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis. Mol. Nutr. Food Res. 2009, 53, 398-406.
35. Qiu, P., Dong, P., Guan, H., Li, S. et al., Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. Mol. Nutr. Food Res. 2010.
36. Pan, M. H., Lai, Y. S., Lai, C. S., Wang, Y. J. et al., 5-Hydroxy-3, 6, 7, 8, 3', 4'-hexamethoxyflavone induces apoptosis through reactive oxygen species production, growth arrest and DNA damage-inducible gene 153 expression, and caspase activation in human leukemia cells. J. Agric. Food Chem. 2007, 55, 5081-5091.
37. Li, S., Sang, S., Pan, M. H., Lai, C. S. et al., Anti-inflammatory property of the urinary metabolites of nobiletin in mouse. Bioorg. Med. Chem. Lett. 2007, 17, 5177-5181.
38. Gotto, A. M., Jr., Pownall, H. J., Havel, R. J., Introduction to the plasma lipoproteins. Meth. Enzymol. 1986, 128, 3-41.
39. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
40. Hermann, M., Gmeiner, B., Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Ann. N.Y. Acad. Sci. 1993, 683, 363-364.
41. Teupser, D., Thiery, J., Walli, A. K., Seidel, D., Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim. Biophys. Acta 1996, 1303, 193-198.
42. Devaraj, S., Hugou, I., Jialal, I., Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages. J. Lipid Res. 2001, 42, 521-527.
43. Basu, S. K., Goldstein, J. L., Anderson, G. W., Brown, M. S., Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 1976, 73, 3178-3182.
44. Mullen, E., Brown, R. M., Osborne, T. F., Shay, N. F., Soy isoflavones affect sterol regulatory element binding proteins (SREBPs) and SREBP-regulated genes in HepG2 cells. J. Nutr. 2004, 134, 2942-2947.
45. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., Mitchell, J. B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987, 47, 936-942.
46. Wang, X., Seed, B., A PCR primer bank for quantitative gene expression analysis. Nucl. Acids Res. 2003, 31, e154.
47. Carter, A. B., Tephly, L. A., Hunninghake, G. W., The absence of activator protein 1-dependent gene expression in THP-1 macrophages stimulated with phorbol esters is due to lack of p38 mitogen-activated protein kinase activation. J. Biol. Chem. 2001, 276, 33826-33832.
48. Tuomisto, T. T., Riekkinen, M. S., Viita, H., Levonen, A. L., Yla-Herttuala, S., Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading - cDNA and protein array study. Atherosclerosis 2005, 180, 283-291.
49. Wang, Y., Zhang, J., Dai, W., Lei, K., Pike, J., Dexamethasone potently enhances phorbol ester-induced IL-1beta gene expression and nuclear factor NF-kappaB activation. J. Immunol. 1997, 159, 534-537.
50. Serkkola, E., Hurme, M., Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-1 beta gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur. J. Biochem. 1993, 213, 243-249.
51. Nagase, M., Abe, J., Takahashi, K., Ando, J. et al., Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J. Biol. Chem. 1998, 273, 33702-33707.
52. Kaufman, P. A., Weinberg, J. B., Greene, W. C., Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells. J. Clin. Invest. 1992, 90, 121-129.
53. Shen, G., Jeong, W. S., Hu, R., Kong, A. N., Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid. Redox. Signal. 2005, 7, 1648-1663.
54. Janssens, S., Beyaert, R., Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 2003, 11, 293-302.
55. Viatour, P., Merville, M. P., Bours, V., Chariot, A., Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 2005, 30, 43-52.
56. Chang, Z. L., Beezhold, D. H., Protein kinase C activation in human monocytes: regulation of PKC isoforms. Immunology 1993, 80, 360-366.
57. Han, S., Sidell, N., Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunology 2002, 106, 53-59.
58. Kunjathoor, V. V., Febbraio, M., Podrez, E. A., Moore, K. J. et al., Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 2002, 277, 49982-49988.
59. Tsukamoto, K., Kinoshita, M., Kojima, K., Mikuni, Y. et al., Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. J. Atheroscler. Thromb. 2002, 9, 57-64.
60. Brown, M. S., Goldstein, J. L., Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 2009, 50, S15-S27.
61. Hua, X., Sakai, J., Ho, Y. K., Goldstein, J. L., Brown, M. S., Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J. Biol. Chem. 1995, 270, 29422-29427.
62. Krycer, J. R., Kristiana, I., Brown, A. J., Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3. PLoS ONE 2009, 4, e8496.
63. Wu, X., Sakata, N., Lui, E., Ginsberg, H. N., Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J. Biol. Chem. 1994, 269, 12375-12382.
64. Miller, L. J., Schwarting, R., Springer, T. A., Regulated expression of the Mac-1, LFA-1, p150, 95 glycoprotein family during leukocyte differentiation. J. Immunol. 1986, 137, 2891-2900.
65. Nelsen, B., Hellman, L., Sen, R., The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol. Cell. Biol. 1988, 8, 3526-3531.
66. Angel, P., Karin, M., The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1991, 1072, 129-157.
67. Mietus-Snyder, M., Glass, C. K., Pitas, R. E., Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBP?: both AP-1 binding and JNK activation are induced by phorbol esters and oxidative stress. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1440-1449.
68. Armesilla, A. L., Vega, M. A., Structural organization of the gene for human CD36 glycoprotein. J. Biol. Chem. 1994, 269, 18985-18991.
69. Ferreira, V., van Dijk, K. W., Groen, A. K., Vos, R. M. et al., Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation. Atherosclerosis 2007, 192, 283-290.
70. Minden, A., Lin, A., Smeal, T., Derijard, B. et al., c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 1994, 14, 6683-6688.
71. Frost, J. A., Geppert, T. D., Cobb, M. H., Feramisco, J. R., A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. USA 1994, 91, 3844-3848.
72. DeSilva, D. R., Feeser, W. S., Tancula, E. J., Scherle, P. A., Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. J. Exp. Med. 1996, 183, 2017-2023.
73. Seger, R., Krebs, E. G., The MAPK signaling cascade. FASEB J. 1995, 9, 726-735.
74. Franklin, C. C., Kraft, A. S., Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 1997, 272, 16917-16923.
75. Davalos, A., Fernandez-Hernando, C., Cerrato, F., Martinez-Botas, J. et al., Red grape juice polyphenols alter cholesterol homeostasis and increase LDL-receptor activity in human cells in vitro. J. Nutr. 2006, 136, 1766-1773.